LIGABUE, Giulia
 Distribuzione geografica
Continente #
EU - Europa 7.898
NA - Nord America 6.876
AS - Asia 4.307
SA - Sud America 565
AF - Africa 121
OC - Oceania 14
Continente sconosciuto - Info sul continente non disponibili 4
Totale 19.785
Nazione #
US - Stati Uniti d'America 6.700
IT - Italia 4.660
SG - Singapore 1.322
CN - Cina 1.221
DE - Germania 809
GB - Regno Unito 765
VN - Vietnam 506
HK - Hong Kong 474
BR - Brasile 414
SE - Svezia 373
RU - Federazione Russa 280
NL - Olanda 206
FR - Francia 198
FI - Finlandia 172
KR - Corea 149
IN - India 112
CA - Canada 94
TR - Turchia 92
UA - Ucraina 84
ID - Indonesia 83
BD - Bangladesh 72
AR - Argentina 57
BG - Bulgaria 53
MX - Messico 52
JP - Giappone 48
ES - Italia 44
IQ - Iraq 36
ZA - Sudafrica 32
PL - Polonia 31
CH - Svizzera 28
PK - Pakistan 27
MA - Marocco 26
BE - Belgio 23
CZ - Repubblica Ceca 22
AT - Austria 19
IE - Irlanda 19
IR - Iran 19
MY - Malesia 19
EC - Ecuador 18
VE - Venezuela 18
LT - Lituania 16
AE - Emirati Arabi Uniti 15
CL - Cile 15
CO - Colombia 15
PT - Portogallo 13
UZ - Uzbekistan 13
AU - Australia 12
PE - Perù 12
AZ - Azerbaigian 11
DZ - Algeria 11
EG - Egitto 11
IL - Israele 11
RO - Romania 11
KE - Kenya 10
TW - Taiwan 10
AL - Albania 9
PH - Filippine 9
PY - Paraguay 9
SA - Arabia Saudita 9
TN - Tunisia 9
CR - Costa Rica 8
DK - Danimarca 8
JO - Giordania 8
MT - Malta 8
SI - Slovenia 8
BY - Bielorussia 7
DO - Repubblica Dominicana 7
KZ - Kazakistan 7
NO - Norvegia 6
NP - Nepal 6
PA - Panama 6
NG - Nigeria 5
RS - Serbia 5
GR - Grecia 4
HR - Croazia 4
MD - Moldavia 4
OM - Oman 4
BO - Bolivia 3
GE - Georgia 3
JM - Giamaica 3
KH - Cambogia 3
TH - Thailandia 3
UY - Uruguay 3
BH - Bahrain 2
EU - Europa 2
KG - Kirghizistan 2
LB - Libano 2
LV - Lettonia 2
MC - Monaco 2
MK - Macedonia 2
MZ - Mozambico 2
NZ - Nuova Zelanda 2
PS - Palestinian Territory 2
SN - Senegal 2
XK - ???statistics.table.value.countryCode.XK??? 2
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BF - Burkina Faso 1
Totale 19.760
Città #
Singapore 855
Ashburn 799
Santa Clara 740
Fairfield 548
Southend 459
Hong Kong 458
San Jose 439
Hefei 428
Milan 424
Chandler 392
Rome 319
Woodbridge 289
Houston 253
Seattle 211
Cambridge 204
Wilmington 203
Beijing 195
Nyköping 187
Ann Arbor 168
London 165
Ho Chi Minh City 159
Seoul 139
Jacksonville 138
Naples 137
Dearborn 132
Council Bluffs 126
Hanoi 124
Los Angeles 118
Modena 117
New York 117
Helsinki 116
The Dalles 89
Bologna 86
Munich 73
Dallas 71
Turin 69
Bari 66
Florence 65
Frankfurt am Main 62
Lauterbourg 62
Moscow 53
Chicago 52
Jakarta 52
Parma 48
San Diego 48
São Paulo 48
Princeton 47
Sofia 47
Buffalo 44
Catania 43
Shanghai 42
Orem 41
Izmir 39
Palermo 36
Tokyo 36
Genoa 33
Eugene 32
Fremont 32
Verona 32
Nuremberg 30
Brescia 29
Des Moines 29
Redwood City 29
Reggio Emilia 29
Montreal 25
Padova 25
Falls Church 23
Guangzhou 23
Toronto 23
Warsaw 23
Atlanta 21
Da Nang 21
Kent 21
Phoenix 21
Salerno 21
Cagliari 20
Livorno 20
Lucca 20
Turku 20
Monza 19
Denver 18
Durham 18
Salt Lake City 18
Amsterdam 17
Bremen 17
Venice 17
Baghdad 16
Brussels 16
Haiphong 16
Poplar 16
Chennai 15
Mexico City 15
Perugia 15
Wuhan 15
Boardman 14
Columbus 14
Dublin 14
Norwalk 14
Rio de Janeiro 14
Brooklyn 13
Totale 11.411
Nome #
Effetto della N-acetilcisteina sulla progressione dell'insufficienza renale cronica nel ratto 4.254
Clinical outcome of kidney transplantation in HIV-infected recipients: a retrospective study 424
CD133 and CD24 expression in renal tissue of patients affected by autosomal dominant polcystic kidney disease 403
Interstitial fluid obtained from kidney biopsy as new source of renal biomarkers 393
Evaluation of a system for sorbent-assisted peritoneal dialysis in a uremic pig model 369
Identification and Characterization of New Proteins in Podocyte Dysfunction of Membranous Nephropathy by Proteomic Analysis of Renal Biopsy 361
The prevalence of autosomal dominant polycystic kidney disease (ADPKD): A meta-analysis of European literature and prevalence evaluation in the Italian province of Modena suggest that ADPKD is a rare and underdiagnosed condition 355
Activation of coagulation during hemodialysis: Effect of blood lines alone and whole extracorporeal circuit 351
GREASE II. A phase II randomized, 12-month, parallel-group, superiority study to evaluate the efficacy of a Modified Atkins Diet in Autosomal Dominant Polycystic Kidney Disease patients 349
P-Cresol and Cardiovascular Risk in Kidney Transplant Recipients 343
Rhodococcus equi Pneumonia in Kidney Transplant Recipient Affected by Acute Intermittent Porphyria: A Case Report 339
Confidence Calibration for Deep Renal Biopsy Immunofluorescence Image Classification 337
Evaluation of the Classification Accuracy of the Kidney Biopsy Direct Immunofluorescence through Convolutional Neural Networks 329
Identification and characterization of a new autoimmune protein in membranous nephropathy by immunoscreening of a renal cDNA library 328
Immunophenotypic Profile and Clinical Outcome of Monoclonal B-cell Lymphocytosis in Kidney Transplantation 322
Automated Prediction of Kidney Failure in IgA Nephropathy with Deep Learning from Biopsy Images 320
A functionally active RAR alpha nuclear receptor is expressed in retinoic acid non responsive early myeloblastic cell lines 313
Efficacy of Belimumab for active lupus nephritis in a young Hispanic woman intolerant to standard treatment: a case report 308
I polimorfismi del gene dell’enzima di conversione dell’angiotensina (ACE) nel rene policistico autosomico dominante (ADPKD) 286
[Dyslipidemia and the risk of kidney disease]. 283
Il rene policistico autosomico dominante (ADPKD): aspetti genetico-molecolari, clinici ed epidemiologici nella provincia di Modena. 280
Genotype-renal function correlation in type 2 autosomal dominant polycystic kidney disease 272
Water treatment and monitor disinfection 271
Relapse of atypical hemolytic uremic syndrome during pregnancy in a patient on eculizumab maintenance treatment: A case report 271
The Role of PEC Progenitors in ADPKD Progression 265
Acid base disorders in patients with COVID-19 261
A validated model of disease progression in IgA nephropathy 260
Proteomic analysis of urine from proteinuric patients shows a proteolitic activity directed against albumin 251
In vitro efficacy and safety of a system for sorbent-assisted peritoneal dialysis 251
#5187 GREASE II: A PHASE II RANDOMIZED, 24-MONTH, PARALLEL-GROUP, SUPERIORITY STUDY TO EVALUATE THE EFFICACY OF A KETOGENIC DIET IN ADPKD PATIENTS 245
Epidermal growth factor receptor polymorphism and autosomal dominant polycystic kidney disease 245
Detection of predictive urinary biomarkers of nephropathy in type 1 and type 2 diabetes by proteomic analysis 245
Oxalate Nephropathy Caused by Excessive Vitamin C Administration in 2 Patients With COVID-19 239
Interstitiome: a novel proteomic discipline applied to renal biopsy 235
COVID-19 Rapid Antigen Test Screening in Patients on Hemodialysis 233
Post-transplant recurrence of glomerulonephritis: a complex clinical case. 232
FP808EARLY IDENTIFICATION OF SICKLE CELL NEPHROPATHY IN A COHORT OF CHILDREN WITH SICKLE CELL DISEASE 232
Screening of a kidney cDNA library for the identification of autoimmune proteins from serum of membranous nephropathy patients. 231
Screening of a kidney cDNA library for the identification of autoimmune proteins from serum of membranous nephropathy patients. 228
P-cresolo solfato e rischio cardiovascolare nel paziente trapiantato 226
The underlying cause of kidney disease is often unknown in dialysis patients: a possible genomic approach 220
Influence of dialysate temperature on creatinine peritoneal clearance in peritoneal dialysis patients: a randomized trial 212
Combining telemedicine and in-person visits to deliver care to patients with severe chronic kidney disease (CKD): Lessons learned from COVID-19 209
Clinical Predictors of Nondiabetic Kidney Disease in Patients with Diabetes: A Single-Center Study 209
Immunosuppressive therapy reduction and early post-infection graft function in kidney transplant recipients with COVID-19 188
Risk of bleeding after percutaneous native kidney biopsy in patients receiving low-dose aspirin: a single-center retrospective study 187
AKI in hospitalized patients with COVID-19: a single-center experience 183
Risk of infections related to endovascular catheters and cardiac implantable devices in hemodialysis patients 175
Reversed high-flux SUPRA HFR: a proof of concept pilot study to access the middle molecular weight uremic toxins 173
Weekly Rapid Antigen Test Screening for COVID-19 in Patients on Hemodialysis 173
Prolonged RT-PCR test positivity in hemodialysis patients with COVID-19 163
Rethinking Chronic Kidney Disease in the Aging Population 159
Towards the monitoring of dialysis treatment through absorption and endogenous fluorescence techniques 149
Seroconversion after COVID-19 vaccine in a dialysis patient on immunosuppressants 146
Il centro dialisi ecosostenibile 137
Reactogenicity of COVID-19 vaccine in hemodialysis patients: a single-center retrospective study 135
Rationale and design of the CORDIAL first-in-human clinical trial: a system for sorbent-assisted continuous flow peritoneal dialysis 128
Prevalence, clinical course and outcomes of COVID-19 in peritoneal dialysis (PD) patients: a single-center experience 127
Screening for nasal carriage of Staphylococcus (S.) aureus reduces the risk of S. aureus peritonitis in patients on peritoneal dialysis (PD) 125
Middle-Molecular Weight Toxin Removal: Asymmetric Cellulose Triacetate vs. Helicoidal Polysulfone during Online Hemodiafiltration (CHORALS Study) 116
Migrants on hemodialysis (HD): clinical characteristics, outcome and quality of life 113
Long-term mortality and technique survival in peritoneal dialysis patients: a 25-year retrospective analysis in a single center 101
Formative usability test of a novel device for peritoneal dialysis (WEAKID) 98
Diagnostic Yield and Clinical Impact of a Small Genetic Panel for Kidney Disease: A Multicenter, Retrospective European Study 90
Improving the sustainability and quality of kidney health care through life cycle assessments, quality improvement, education and technical innovations: the KitNewCare approach 82
Validation of Hemoglobin and Hematocrit Measurements from a Dialysis Machine Sensor Compared to Laboratory Analysis: A Cross-Sectional Study 81
A life cycle assessment of peritoneal dialysis procurement in Italy: environmental burden and opportunities for improvement 67
Intradialytic clearances and reduction ratios for middle molecular weight uremic toxins and protein-bound uremic toxins: comparison of hemodiafiltration with asymmetric cellulose triacetate vs hemodiafiltration with helycoidal polysulfone during a 6-month follow-up 37
Rationale and design of the CORDIAL first-in-human clinical trial: A system for sorbent-assisted continuous flow peritoneal dialysis 33
Sustainable kidney care: A life cycle assessment of the peritoneal dialysis pathways 28
Theoretically redesigning peritoneal dialysis products for sustainability: A life cycle inventory approach 28
#2314 Greenhouse gas emissions from the special waste incineration: a comparative analysis between a large Dialysis Center and a University Hospital 27
Assessing middle-molecular and protein-bound uremic toxins: a six month study of ATA vs PS membranes in hemodiafiltration 25
Green haemodialysis: comparison of dialysis bags versus fresenius granumix at the AOU Policlinico di Modena, Italy 23
Twelve-Month Evaluation of Middle Molecule (MMUT) and Protein-Bound Uremic Toxin (PBUT) Removal with Two Different Hemodiafiltration Filters 21
Comparing environmental footprints of haemodialysis and online haemodiafiltration in Italy 18
Genomic Approaches for Monogenic Kidney Diseases: A Comparative Review of Diagnostic Methods and Precision Medicine Implications 1
Totale 19.927
Categoria #
all - tutte 62.340
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 62.340


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021175 0 0 0 0 0 0 0 0 0 0 117 58
2021/20221.117 71 93 65 110 50 98 53 54 107 77 213 126
2022/20231.981 126 173 94 171 168 274 136 216 189 113 179 142
2023/20242.501 111 118 200 244 291 246 302 255 119 181 201 233
2024/20254.429 245 232 230 345 624 605 401 281 435 202 375 454
2025/20265.990 454 295 498 694 828 383 864 334 680 699 261 0
Totale 19.927